Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      India imported APIs worth Rs 18,372.54 crore in 2016-17

      India imported APIs worth Rs 18,372.54 crore in 2016-17

      Ruby Khatun Khatun7 Jan 2018 10:30 AM IST
      New Delhi: India imported Active Pharmaceutical Ingredients (APIs) worth Rs 18,372.54 crore in 2016-17, of which the maximum was from China,...
      Pharma sector earnings to remain muted in Dec quarter: Edelweiss Securities

      Pharma sector earnings to remain muted in Dec quarter: Edelweiss Securities

      Ruby Khatun Khatun7 Jan 2018 10:00 AM IST
      New Delhi: Pharma sector's December quarter revenue is estimated to remain flat, while profits are likely to slip owing to decline in US businesses...
      CCI begins public consultation on Bayer-Monsanto deal

      CCI begins public consultation on Bayer-Monsanto deal

      Ruby Khatun Khatun7 Jan 2018 10:00 AM IST
      New Delhi: Fair trade regulator Competition Commission (CCI) launched a public scrutiny of finer details of the proposed USD 66 billion Bayer-Monsanto...
      Triesta Unit of HCG to combine with Strand Life Sciences

      Triesta Unit of HCG to combine with Strand Life Sciences

      Ruby Khatun Khatun7 Jan 2018 9:45 AM IST
      New Delhi: Healthcare Global Enterprises announced the execution of definitive agreements for the business combination of its unit Triesta Sciences...
      Sangamo partners with Pfizer to develop gene therapy for ALS

      Sangamo partners with Pfizer to develop gene therapy for ALS

      Ruby Khatun Khatun7 Jan 2018 9:30 AM IST
      Sangamo Therapeutics Inc and Pfizer Inc said on Wednesday they would work together to develop a gene therapy to treat ALS, a disease that affects...
      Fortis plans to raise Rs 5,000 crore: Report

      Fortis plans to raise Rs 5,000 crore: Report

      Ruby Khatun Khatun6 Jan 2018 12:30 PM IST
      Fortis Healthcare is seeking a cash injection of $790 million (Rs 5,000 crore) as part of its billionaire founders’ talks to sell their stake in...
      Lupin launches generic anti-infection capsules in US

      Lupin launches generic anti-infection capsules in US

      Ruby Khatun Khatun6 Jan 2018 11:30 AM IST
      New Delhi: Drug major Lupin said it has launched Flucytosine capsules, used to treat serious infections, in the American market.The company has...
      Bids sought from advisors for sale of Dredging Corp, HLL

      Bids sought from advisors for sale of Dredging Corp, HLL

      Ruby Khatun Khatun6 Jan 2018 11:00 AM IST
      New Delhi: The government invited bids from transaction advisors for the sale process of three PSUs, including Dredging Corporation of India.The...
      Aarti Drugs board to consider shares buyback next week

      Aarti Drugs board to consider shares buyback next week

      Ruby Khatun Khatun6 Jan 2018 10:45 AM IST
      New Delhi: Aarti Drugs said its board will meet next week to consider a share buyback proposal."A meeting of the board of directors of the company is...
      Sterling Biotech money laundering case: Court tells ED dont pick and choose, catch big fish too

      Sterling Biotech money laundering case: Court tells ED don't pick and choose, catch big fish too

      Ruby Khatun Khatun6 Jan 2018 10:30 AM IST
      New Delhi: A special court came down heavily on the Enforcement Directorate (ED) saying the agency should not adopt a pick and choose the policy and...
      BiondVax universal flu vaccine patent granted in India

      BiondVax universal flu vaccine patent granted in India

      Ruby Khatun Khatun6 Jan 2018 10:10 AM IST
      NESS ZIONA, Israel: BiondVax Pharmaceuticals Ltd., developer of M-001, the Universal Flu Vaccine candidate currently in preparation for a Phase 3...
      Novartis Promacta receives FDA breakthrough designation for new indication

      Novartis Promacta receives FDA breakthrough designation for new indication

      Ruby Khatun Khatun6 Jan 2018 10:00 AM IST
      ZURICH: Novartis drug Promacta has received breakthrough therapy designation from the U.S. Food and Drug Administration for first-line treatment of...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok